There were 210 press releases posted in the last 24 hours and 431,487 in the last 365 days.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, ALR

NEW YORK, Feb. 19, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Cardiovascular Systems, Inc. (NASDAQ: CSII)’s sale to Abbott Laboratories for $20.00 per common share. If you are a Cardiovascular shareholder, click here to learn more about your rights and options.

NuVasive, Inc. (NASDAQ: NUVA)’s sale to Globus Medical, Inc. for 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock. If you are a NuVasive shareholder, click here to learn more about your rights and options.

AlerisLife Inc. (NASDAQ: ALR)’s sale to ABP Acquisition LLC for $1.31 per share in cash. If you are an AlerisLife shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com  
https://www.halpersadeh.com


Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.